Literature DB >> 3381055

Behavioral versus EEG-based monitoring of all-night sleep/wake patterns.

R D Ogilvie1, R T Wilkinson.   

Abstract

Faint tones were presented at intervals (average 16 s) throughout a night's sleep; whenever they heard them, subjects pressed a palm-mounted button to switch them off. At the same time, electroencephalogram (EEG) was recorded. Button-press responses occurred in all EEG stages of sleep except Stage 4, although there was only one behavioral response (BR) in Stage 3 and one in REM. The mean probability of response (PR)/Stage was Stage 1 = 0.235, Stage 2 = 0.016, Stage 3 = 0.001, Stage 4 = 0.000, Stage REM = 0.0004. Also, responses sometimes failed to occur in EEG Stage wake (PR = 0.94), particularly near sleep onset. If the criterion for wakefulness is cognitive response to external stimulation, only in EEG Stages 3, 4, and REM can accurate distinctions between sleep and wakefulness be made. If EEG is the criterion, then the data suggest that cognitive response is possible during Stages 1 and 2 "sleep." The concept of a sleep onset period (SOP), characterized by lengthening response times and intermittent response failure (thereby reflecting neither true sleep or wakefulness), may provide a useful resolution of this definitional dilemma.

Mesh:

Year:  1988        PMID: 3381055     DOI: 10.1093/sleep/11.2.139

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  2 in total

1.  Hippocampal population activity during the small-amplitude irregular activity state in the rat.

Authors:  Beata Jarosiewicz; Bruce L McNaughton; William E Skaggs
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

2.  Tracking the sleep onset process: an empirical model of behavioral and physiological dynamics.

Authors:  Michael J Prerau; Katie E Hartnack; Gabriel Obregon-Henao; Aaron Sampson; Margaret Merlino; Karen Gannon; Matt T Bianchi; Jeffrey M Ellenbogen; Patrick L Purdon
Journal:  PLoS Comput Biol       Date:  2014-10-02       Impact factor: 4.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.